NCM
Nelson Capital Management’s Caribou Biosciences CRBU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Hold |
85,020
| – | – | 0.01% | 101 |
|
|
2025
Q1 | $77.6K | Buy |
85,020
+20,162
| +31% | +$18.4K | 0.01% | 101 |
|
|
2024
Q4 | $103K | Sell |
64,858
-20,162
| -24% | -$32.1K | 0.02% | 107 |
|
|
2024
Q3 | $167K | Hold |
85,020
| – | – | 0.03% | 109 |
|
|
2024
Q2 | $139K | Hold |
85,020
| – | – | 0.02% | 105 |
|
|
2024
Q1 | $437K | Hold |
85,020
| – | – | 0.08% | 83 |
|
|
2023
Q4 | $487K | Hold |
85,020
| – | – | 0.11% | 76 |
|
|
2023
Q3 | $406K | Hold |
85,020
| – | – | 0.1% | 76 |
|
|
2023
Q2 | $361K | Hold |
85,020
| – | – | 0.09% | 76 |
|
|
2023
Q1 | $451K | Hold |
85,020
| – | – | 0.13% | 72 |
|
|
2022
Q4 | $534K | Hold |
85,020
| – | – | 0.16% | 73 |
|
|
2022
Q3 | $897K | Hold |
85,020
| – | – | 0.26% | 68 |
|
|
2022
Q2 | $462K | Buy |
85,020
+20,162
| +31% | +$110K | 0.13% | 79 |
|
|
2022
Q1 | $595K | Buy |
+64,858
| New | +$595K | 0.12% | 80 |
|